FDA

Akeso, Inc., a prominent company in the biopharmaceutical sector, has revealed that its two pioneering bispecific antibody drugs—cadonilimab (a PD-1/CTLA-4 bispecific antibody) and ivonescimab (a PD-1/VEGF bispecific antibody)—have been added to the latest edition of the National Reimbursement Drug List […]

Formosa Pharmaceuticals, based in Taiwan, has successfully secured an exclusive licensing deal with Switzerland’s Medvisis Switzerland AG for the rights to market the innovative clobetasol propionate ophthalmic suspension, 0.05% (APP13007), in Switzerland and Liechtenstein. This formulation is designed to treat

The recently reformed Standing Committee on Chemicals and Fertilizers, led by Lok Sabha member Kirti Azad Jha, is set to explore critical issues within the pharmaceutical sector. These include the rising cost of medications and the pressing need for tighter

The pharmaceutical sector is experience a paradigm shift, propelled by the integration of artificial intelligence (AI) and digital advancements, taking drug discovery, development, and healthcare services to unprecedented levels. Dr. Kunal Mohan Gokhale, serving as an assistant professor at Mumbai’s

The Pharmaceuticals Department has confirmed the decision of the nation’s drug price regulator to set a maximum price for the antiviral medication acyclovir 800 mg per tablet, dismissing an appeal from Cipla Ltd. Cipla, whose portfolio includes the Acivir 800

Clinical trials rooted in evidence form the backbone of advancing surgical technology in India. By affirming new instruments and methodologies, these studies enhance patient results, influence policy creation, and ensure that technological breakthroughs remain accessible, efficient, and safe for a

In anticipation of the upcoming West Bengal state pharmacy council elections, the United Pharmacists Forum (UPF), the sole coalition of pharmacist organizations, has unveiled its election manifesto pledging 18 commitments to the state’s registered pharmacist community. Upon securing victory in

The Organisation of Pharmaceutical Producers of India (OPPI) held its prominent Annual Summit in New Delhi, bringing together an esteemed gathering of government officials, regulators, industry pioneers, academic figures, patient support organizations, innovators, and other vital stakeholders. Under the theme

Boehringer Ingelheim has introduced the latest innovation in Marek’s disease vaccines to the Indian market, marking a significant advancement. This state-of-the-art vaccine utilizes a unique controlled attenuation technique, ensuring a superior balance of protection and safety. Marek’s disease continues to

Continuing their mission to deliver the most pioneering cancer treatments to India at accessible prices, the Thane-based SunAct Cancer Institute has forged a partnership with Malaysian innovators Abgentil Biomedical SDN BHD to roll out CAR-T, TCR, and TIL therapies for